Among the 13 genes, the methylation frequencies of 7 genes (MYF6, SIX6, SOX1, RARB, BCL2, PHOX2A and FOLX2) had significant difference between the group of stage I NSCLC and the group of non-cancerous lung diseases (Table III). This evidence concerns the gene BCL2 and lung disorder.